Published in Surg Forum on January 01, 1976
Refined crystal structure of beta-lactamase from Citrobacter freundii indicates a mechanism for beta-lactam hydrolysis. Nature (1990) 3.56
Comparative results of cadaver and related donor renal homografts in man, and immunologic implications of the outcome of second and paired transplants. Ann Surg (1966) 3.06
Errors in the technique of intraperitoneal injection of mice. Appl Microbiol (1968) 3.05
The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters. J Virol (1989) 2.65
Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc Natl Acad Sci U S A (1983) 2.54
Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia (2006) 2.53
Relation of lipopolysaccharide character to P1 sensitivity in Salmonella typhimurium. Virology (1974) 2.43
Tissue-shrinkage correction factor in the calculation of prostate cancer volume. Am J Surg Pathol (1996) 2.06
Structural determinants for transcriptional activation by cAMP-responsive DNA elements. J Biol Chem (1988) 1.93
Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo. J Virol (1991) 1.91
Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus. J Virol (1984) 1.88
Correlation of trabecular bone structure with age, bone mineral density, and osteoporotic status: in vivo studies in the distal radius using high resolution magnetic resonance imaging. J Bone Miner Res (1997) 1.86
The Epstein-Barr virus immediate-early gene product, BMLF1, acts in trans by a posttranscriptional mechanism which is reporter gene dependent. J Virol (1989) 1.86
Effect of 12-O-tetradecanoyl-phorbol-13-acetate on the replication of Epstein-Barr virus. I. Characterization of viral DNA. Virology (1979) 1.80
The specificity and importance of humoral antibody in the protection of mice against intraperitoneal challenge with complement-sensitive and complement-resistant Salmonella. J Infect Dis (1970) 1.78
Report of an IEEE task force--an IEEE opinion on research needs for biomedical engineering systems. IEEE Trans Biomed Eng (1986) 1.77
The effect of hospital volume on mortality and resource use after radical prostatectomy. J Urol (2000) 1.60
Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy. J Clin Oncol (1991) 1.57
Stress-inducible transcription factor CHOP/gadd153 induces apoptosis in mammalian cells via p38 kinase-dependent and -independent mechanisms. Exp Cell Res (2001) 1.54
Functional mutation in the promoter region of thrombomodulin gene in relation to carotid atherosclerosis. Atherosclerosis (2001) 1.45
The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder. J Urol (1981) 1.44
Giant cyst of the seminal vesicle with renal agenesis. AJR Am J Roentgenol (1987) 1.43
Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol (1976) 1.41
Vascular dementia of Binswanger's type: clinical, neuroradiological and 99mTc-HMPAO SPET study. Eur J Nucl Med (1996) 1.40
Electrical property sensing biopsy needle for prostate cancer detection. Prostate (2013) 1.39
Panencephalitic Creutzfeldt-Jakob disease. Unusual presentation of magnetic resonance imaging and proton magnetic resonance spectroscopy. J Neurol Sci (1996) 1.38
Response of men with advanced prostatic carcinoma to exogenous administration of testosterone. Cancer (1967) 1.38
Activation of human herpesvirus 8 (HHV-8) thymidine kinase (TK) TATAA-less promoter by HHV-8 ORF50 gene product is SP1 dependent. DNA Cell Biol (1998) 1.34
Some urological aspects of 93 consecutive renal homotransplants in modified recipients. J Urol (1967) 1.32
Trabecular bone architecture in the distal radius using magnetic resonance imaging in subjects with fractures of the proximal femur. Magnetic Resonance Science Center and Osteoporosis and Arthritis Research Group. Osteoporos Int (1999) 1.30
Nephrotic syndrome in heroin addicts. Lancet (1972) 1.28
Impact of spatial resolution on the prediction of trabecular architecture parameters. Bone (1998) 1.26
A new look at bladder neck obstruction by the food and drug administration regulators: guide lines for investigation of benign prostatic hypertrophy. Trans Am Assoc Genitourin Surg (1976) 1.26
Proton radiation as boost therapy for localized prostatic carcinoma. JAMA (1979) 1.25
Ta and T1 bladder cancer: location, recurrence and progression. Br J Urol (1982) 1.24
In vivo description of dendritic cells in human renal cell carcinoma. J Urol (1999) 1.23
In vivo high resolution MRI of the calcaneus: differences in trabecular structure in osteoporosis patients. J Bone Miner Res (1998) 1.23
Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma. Cancer Res (1986) 1.22
Keratin 10 gene expression during differentiation of mouse epidermis requires transcription factors C/EBP and AP-2. Dev Biol (1999) 1.22
Multicenter comparison of PCR assays for detection of human herpesvirus 8 DNA in semen. J Clin Microbiol (1999) 1.22
Carcinoma of the prostate and lymphatic metastases. J Urol (1974) 1.21
Metastatic renal cell carcinoma presenting as a skin nodule: case report and review of the literature. J Urol (1994) 1.21
High-resolution magnetic resonance imaging: three-dimensional trabecular bone architecture and biomechanical properties. Bone (1998) 1.21
Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody. J Virol (1985) 1.20
Identification of two molecular forms of (Na+,K+)-ATPase in rat adipocytes. Relation to insulin stimulation of the enzyme. J Biol Chem (1985) 1.19
Epstein-Barr virus: inhibition of replication by three new drugs. Science (1983) 1.17
Cell cycles in two cell lines of human bladder carcinoma. Tohoku J Exp Med (1977) 1.14
The role of surgery in the potentially curative treatment of bladder carcinoma. Cancer Res (1977) 1.13
Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival. J Urol (1985) 1.12
A comparison of sodium excretion following the infusion of saline into systemic and portal veins in the dog: evidence for a hepatic role in the control of sodium excretion. Clin Sci (1967) 1.11
Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery. Arch Ophthalmol (2000) 1.10
Pinworm granuloma of the liver. Am J Trop Med Hyg (1984) 1.10
Effects of 12-O-tetradecanoyl-phorbol-13-acetate on cell proliferation and Epstein-Barr virus DNA replication. Virology (1982) 1.08
Cytokine release from osteoblasts in response to ultrasound stimulation. Biomaterials (2003) 1.08
Establishment and characterization of four human bladder tumor cell lines and sublines with different degrees of malignancy. Cancer Res (1985) 1.08
Comparative efficacy and selectivity of some nucleoside analogs against Epstein-Barr virus. Antimicrob Agents Chemother (1985) 1.07
Detection of human papillomavirus DNA in colorectal carcinomas by polymerase chain reaction. Gut (1995) 1.05
Venoarterial shunting in obstructive pulmonary disease. N Engl J Med (1968) 1.04
Effect of acupuncture on cardiopulmonary function. Chin Med J (Engl) (1996) 1.04
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone. Cancer (1983) 1.04
Extraction of skin test activity from Coccidioides immitis mycelia by water, perchloric acid, and aqueous phenol extraction. Infect Immun (1978) 1.03
A comparative study of trabecular bone properties in the spine and femur using high resolution MRI and CT. J Bone Miner Res (1998) 1.03
Chemotherapy programs of the National Prostatic Cancer Project (NPCP). Cancer (1980) 1.03
Immunochemical detection of serum prostatic acid phosphatase. Methodology and clinical evaluation. Invest Urol (1978) 1.03
Bladder carcinoma as a systemic disease. Cancer (1979) 1.03
Invasive bladder cancer: tumor configuration, lymphatic invasion and survival. J Urol (1983) 1.02
Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder. N Engl J Med (1987) 1.02
Automated method for monitoring ventricular ectopic beats. Lancet (1968) 1.01
Metabolic activation of 9([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human lymphoblastoid cell lines infected with Epstein-Barr virus. J Virol (1986) 1.00
Acyclovir and Epstein-Barr virus infection. J Antimicrob Chemother (1983) 1.00
Non-surgical retrieval of intravascular foreign body: experience of 12 cases. Eur J Radiol (1994) 1.00
A randomized controlled trial on the treatment for acute partial ischemic stroke with acupuncture. Neuroepidemiology (1993) 0.99
Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging. J Nucl Med (2001) 0.99
Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells. J Virol (1987) 0.99
Radiation therapy for localized prostate carcinoma: experience at the Massachusetts General Hospital (1973-1981). NCI Monogr (1988) 0.98
Transitional cell carcinoma of renal pelvis. Urology (1982) 0.98
Testicular tumors: delay in diagnosis and influence on survival. Am Fam Physician (1984) 0.97
Carcinoma-in-situ of the urothelium. Urol Clin North Am (1976) 0.96
Cellular events in tolerance. IV. The effect of a graft-versus-host reaction and endotoxin on hapten- and carrier-specific tolerance. Eur J Immunol (1974) 0.96
Activation of latent Epstein-Barr virus genomes: selective stimulation of synthesis of chromosomal proteins by a tumor promoter. J Virol (1983) 0.95
Prognostic factors in carcinoma of the ureter. J Urol (1981) 0.95
Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA (1987) 0.95
A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A National Bladder Cancer Collaborative Group A Study. Cancer (1983) 0.94
MRI compatibility and visibility assessment of implantable medical devices. J Magn Reson Imaging (1999) 0.94
T-cell malignant lymphoma with conjunctival involvement. Am J Ophthalmol (1998) 0.94
The heterogeneity of invasive bladder carcinoma and different responses to treatment. J Urol (1980) 0.94
Immunospecificity to non-histone chromosomal proteins of anti-chromatin antibodies. Nat New Biol (1973) 0.94
A microprocessor-based noninvasive arterial pulse wave analyzer. IEEE Trans Biomed Eng (1985) 0.94
Induction of replication of Epstein-Barr virus DNA by 12-O-tetradecanoyl-phorbol-13-acetate. II. Inhibition by retinoic acid and 9-(2-hydroxyethoxymethyl) guanine. Virology (1981) 0.94
Identification of vessels by lectin-immunoperoxidase staining of endothelium: possible applications in urogenital malignancies. J Urol (1984) 0.93
Effect of 514.5-nm argon ion laser radiation on hematoporphyrin derivative-treated bladder tumor cells in vitro and in vivo. J Natl Cancer Inst (1985) 0.93
Vulvar metastases secondary to transitional cell carcinoma of the bladder. A case report. J Reprod Med (1999) 0.93
Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigens. Cancer Res (1985) 0.93
Anisotropy of the elastic modulus of trabecular bone specimens from different anatomical locations. Med Eng Phys (1998) 0.93